HealthStream (HSTM) CTO Jeff Cunningham Receives RSU Award

What Happened
Jeff Cunningham, Chief Technology Officer of HealthStream, was granted a total of 18,474 restricted stock units (RSUs) on September 18, 2026. These awards were reported as derivative grants (transaction code A) with a $0.00 acquisition price — RSUs represent the contingent right to receive shares upon vesting, so there was no cash paid or realized value at grant.

Key Details

• Transaction date: 2026-09-18; Form 4 filed: 2026-09-22 (filed within the 2-business-day reporting window).
• Grant details: three RSU awards of 2,053; 12,316; and 4,105 units, totaling 18,474 RSUs. Acquisition price shown: $0.00 (derivative award).
• Vesting/footnotes:
  • F1: Each RSU converts to one share upon vesting.
  • F2: One award vests over four years at 15% (9/18/2027), 20% (9/18/2028), 30% (9/18/2029), 35% (9/18/2030).
  • F4: One award vests annually in four equal installments beginning 9/18/2027.
  • F5: One award is performance-based (up to 25% vesting per performance year, measured annually with potential vesting on 2/23/2028, 2/23/2029, 2/23/2030, and 2/23/2031).
• Shares owned after the transaction: not specified in this filing.
• No sale or purchase of vested shares occurred; these are future-contingent awards (not an immediate bullish purchase).

Context
RSU grants are a common form of executive compensation designed to retain employees and align incentives; because these RSUs are subject to multi-year service and, for a portion, performance conditions, they do not represent immediately tradable shares or realized cash value. This filing documents the grant (derivative award) rather than any sale, purchase, or exercise of existing shares.